Eye Drops and Lubricants Market by Type (Antibiotics, Hormones, Artificial Tears, and Others) and Application (Eye Diseases, Eye Care, and Others): Global Opportunity Analysis and Industry Forecast, 2018 - 2025

The global eye drops and lubricants market generated $15,587 million in 2017 and is projected to reach $22,625 million by 2025, growing at a CAGR of 4.7% from 2018 to 2025.

Eye drops and lubricants are used to relieve people suffering from various eye problems, such as eye dryness, redness, infection (pink eye), allergies, itching, soreness, swelling, and others. Eye infections such as conjunctivitis and bacterial keratitis are chronic infections treated by using antibiotics therapy. Furthermore, eye and vision problems also occur due to imbalance in hormone levels, as hormones regulate important body functions and fluctuation in them can affect the eyes and vision. The discovery of advanced prospect molecules and novel combination therapies is expected to boost the growth of the eye drops and lubricants market in near future.

Rise in prevalence of ophthalmic disorders worldwide, change in the demographics across the globe, and focus on drug discovery and development for the treatment of eye disorder and diseases are the factors that drive the growth of the global eye drops and lubricants market. However, longer timelines required for the approval of eye drops and lubricants and risk of associated side effects hamper the market growth. On the contrary, surge in investment by manufacturers in the emerging economies and rise in initiatives to reduce the burden of glaucoma globally are anticipated to offer lucrative opportunities for market expansion.

The global eye drops market is segmented based on type, application, and region. By type, the market is categorized into antibiotics, hormones, artificial tears, and others. Based on application, the market is divided into eye diseases, eye care, and others. The eye diseases segment is further classified into dry eye, glaucoma, conjunctivitis, refractive errors, and others. Based on region, it is studied across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

ü This report provides a detailed quantitative analysis of the current market trends and future estimations from 2018 to 2025, which assists to identify the prevailing market opportunities.

ü An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

ü A comprehensive analysis of the factors that drive and restrain the growth of the global eye drops and lubricants market is provided.

ü An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

• By Type

o Antibiotics

o Hormones

o Artificial Tears

o Others

• By Application

o Eye Diseases

§ Dry Eye

§ Glaucoma

§ Conjunctivitis

§ Refractive Errors

§ Others

o Eye Care

o Others

• By Region

o North America

• U.S.

• Canada

• Mexico

o Europe

• Germany

• France

• UK

• Italy

• Spain

• Rest of Europe

o Asia-Pacific

• Australia

• Japan

• India

• China

• Rest of Asia-Pacific

o LAMEA

• Brazil

• Saudi Arabia

• South Africa

• Rest of LAMEA

KEY MARKET PLAYERS

• Akorn Consumer Health (TheraTears)

• Allergan Plc

• Johnson & Johnson

• Novartis International AG (Alcon Inc.)

• Pfizer Inc.

• Prestige Consumer Healthcare, Inc.

• Sager Pharma Kft.

• ROHTO Pharmaceutical Co., Ltd.

• Similasan Corporation USA

• Valeant pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)

The other players in the value chain include (profiles not included in the report):

• Jawa Pharmaceuticals Pvt. Ltd.

• Maya Biotech

• Neiss Labs Ltd.

• Hanuchem Laboratories

• Oculent Healthcar

Chapter: 1: INTRODUCTION

1.1. Report description

1.2. Key benefits for stakeholders

1.3. Key market segments

1.4. Research methodology

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools & models

Chapter: 2: EXECUTIVE SUMMARY

2.1. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope

3.2. Key findings

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.3. Porter’s five forces analysis

3.4. Top player positioning, 2017

3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rise in prevalence of ophthalmic disorders worldwide

3.5.1.2. Change in the demographics across the globe

3.5.1.3. Drug discovery and development

3.5.2. Restraints

3.5.2.1. Longer timelines required for the development of eye drops and lubricants

3.5.2.2. Risk of side effects associated with eye drops and lubricants

3.5.3. Opportunity

3.5.3.1. Increase in investment by market players in the emerging economies

Chapter: 4: EYE DROPS AND LUBRICANTS MARKET, BY TYPE

4.1. Overview

4.1.1. Market size and forecast

4.2. Antibiotics

4.2.1. Key market trends, growth factors, and opportunities

4.2.2. Market size and forecast, by region

4.2.3. Market analysis, by country

4.3. Hormones

4.3.1. Key market trends, growth factors, and opportunities

4.3.2. Market size and forecast, by region

4.3.3. Market analysis, by country

4.4. Artificial tears

4.4.1. Key market trends, growth factors, and opportunities

4.4.2. Market size and forecast, by region

4.4.3. Market analysis, by country

4.5. Others

4.5.1. Key market trends, growth factors, and opportunities

4.5.2. Market size and forecast, by region

4.5.3. Market analysis, by country

Chapter: 5: GLOBAL EYE-DROP AND LUBRICANTS MARKET BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast, by region

5.2. Eye diseases

5.2.1. Market size and forecast, by type

5.2.1.1. Dry Eye

5.2.1.1.1. Market size and forecast

5.2.1.2. Glaucoma

5.2.1.2.1. Market size and forecast

5.2.1.3. Conjunctivitis

5.2.1.3.1. Market size and forecast

5.2.1.4. Refractive Errors

5.2.1.4.1. Market size and forecast

5.2.1.5. Others

5.2.1.5.1. Market size and forecast

5.2.2. Market size and forecast, by region

5.2.3. Market analysis, by country

5.3. Eye care

5.3.1. Market size and forecast, by region

5.3.2. Market analysis, by country

5.4. Others

5.4.1. Market size and forecast by region

5.4.2. Market analysis, by country

Chapter: 6: EYE DROPS AND LUBRICANT MARKET, BY REGION

6.1. Overview

6.1.1. Market size and forecast

6.2. North America

6.2.1. Key market trends and opportunities

6.2.2. North America eye drops and lubricant market, by type

6.2.3. North America eye drops and lubricant market, by application

6.2.4. North America eye drops and lubricant market, by country

6.2.4.1. U.S. eye drops and lubricant market, by type

6.2.4.2. U.S. eye drops and lubricant market, by application

6.2.4.3. Canada eye drops and lubricant market, by type

6.2.4.4. Canada eye drops and lubricant market, by application

6.2.4.5. Mexico eye drops and lubricant market, by type

6.2.4.6. Mexico eye drops and lubricant market, by application

6.3. Europe

6.3.1. Key market trends and opportunities

6.3.2. Europe eye drops and lubricant market, by type

6.3.3. Europe eye drops and lubricant market, by application

6.3.4. Europe eye drops and lubricant market, by country

6.3.4.1. Germany eye drops and lubricant market, by type

6.3.4.2. Germany eye drops and lubricant market, by application

6.3.4.3. France eye drops and lubricant market, by type

6.3.4.4. France eye drops and lubricant market, by application

6.3.4.5. UK eye drops and lubricant market, by type

6.3.4.6. UK eye drops and lubricant market, by application

6.3.4.7. Italy eye drops and lubricant market, by type

6.3.4.8. Italy eye drops and lubricant market, by application

6.3.4.9. Spain eye drops and lubricant market, by type

6.3.4.10. Spain eye drops and lubricant market, by application

6.3.4.11. Rest of Europe eye drops and lubricant market, by type

6.3.4.12. Rest of Europe eye drops and lubricant market, by application

6.4. Asia-Pacific

6.4.1. Key market trends and opportunities

6.4.2. Asia-Pacific eye drops and lubricant market, by type

6.4.3. Asia-Pacific eye drops and lubricant market, by application

6.4.4. Asia-Pacific eye drops and lubricant market, by country

6.4.4.1. Japan eye drops and lubricant market, by type

6.4.4.2. Japan eye drops and lubricant market, by application

6.4.4.3. China eye drops and lubricant market, by type

6.4.4.4. China eye drops and lubricant market, by application

6.4.4.5. India eye drops and lubricant market, by type

6.4.4.6. India eye drops and lubricant market, by application

6.4.4.7. Australia eye drops and lubricant market, by type

6.4.4.8. Australia eye drops and lubricant market, by application

6.4.4.9. South Korea eye drops and lubricant market, by type

6.4.4.10. South Korea eye drops and lubricant market, by application

6.4.4.11. Rest of Asia-Pacific eye drops and lubricant market, by type

6.4.4.12. Rest of Asia-Pacific eye drops and lubricant market, by application

6.5. LAMEA

6.5.1. Key market trends and opportunities

6.5.2. LAMEA eye drops and lubricant market, by type

6.5.3. LAMEA eye drops and lubricant market, by application

6.5.4. LAMEA eye drops and lubricant market, by country

6.5.4.1. Brazil eye drops and lubricant market, by type

6.5.4.2. Brazil eye drops and lubricant market, by application

6.5.4.3. Saudi Arabia eye drops and lubricant market, by type

6.5.4.4. Saudi Arabia eye drops and lubricant market, by application

6.5.4.5. Rest of LAMEA eye drops and lubricant market, by type

6.5.4.6. Rest of LAMEA eye drops and lubricant market, by application

Chapter: 7: COMPANY PROFILES

7.1. AKORN CONSUMER HEALTH (THERATEARS)

7.1.1. Company overview

7.1.2. Company snapshot

7.1.3. Product portfolio

7.2. ALLERGAN PLC.

7.2.1. Company overview

7.2.2. Company snapshot

7.2.3. Operating business segments

7.2.4. Product portfolio

7.2.5. Business performance

7.2.6. Key strategic moves and developments

7.3. JOHNSON & JOHNSON

7.3.1. Company overview

7.3.2. Company snapshot

7.3.3. Operating business segments

7.3.4. Product portfolio

7.3.5. Business performance

7.3.6. Key strategic moves and developments

7.4. NOVARTIS INTERNATIONAL AG (ALCON INC.)

7.4.1. Company overview

7.4.2. Company snapshot

7.4.3. Operating business segments

7.4.4. Product portfolio

7.4.5. Business performance

7.4.6. Key strategic moves and developments

7.5. PFIZER INC.

7.5.1. Company overview

7.5.2. Company snapshot

7.5.3. Operating business segments

7.5.4. Product portfolio

7.5.5. Business performance

7.6. PRESTIGE CONSUMER HEALTHCARE, INC.

7.6.1. Company overview

7.6.2. Company snapshot

7.6.3. Product portfolio

7.7. SAGER PHARMA KFT.

7.7.1. Company overview

7.7.2. Company snapshot

7.7.3. Operating business segments

7.7.4. Product Portfolio

7.8. ROHTO PHARMACEUTICAL CO., LTD.

7.8.1. Company overview

7.8.2. Company snapshot

7.8.3. Operating business segments

7.8.4. Product portfolio

7.8.5. Business performance

7.8.6. Key strategic moves and developments

7.9. SIMILASAN CORPORATION USA

7.9.1. Company overview

7.9.2. Company snapshot

7.9.3. Product portfolio

7.10. VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (BAUSCH & LOMB INCORPORATED)

7.10.1. Company overview

7.10.2. Company snapshot

7.10.3. Operating business segments

7.10.4. Product portfolio

7.10.5. Business performance

7.10.6. Key strategic moves and development

LIST OF TABLES

TABLE 01. GLOBAL EYE DROPS AND LUBRICANTS MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 02. EYE DROPS AND LUBRICANTS MARKET FOR ANTIBIOTICS, BY REGION, 2017–2025 ($MILLION)

TABLE 03. EYE DROPS AND LUBRICANTS MARKET FOR HORMONES, BY REGION, 2017–2025 ($MILLION)

TABLE 04. EYE DROPS AND LUBRICANTS MARKET FOR ARTIFICIAL TEARS, BY REGION, 2017–2025 ($MILLION)

TABLE 05. EYE DROPS AND LUBRICANTS MARKET FOR OTHER TYPES, BY REGION, 2017–2025 ($MILLION)

TABLE 06. GLOBAL EYE-DROP AND LUBRICANTS MARKET BY APPLICATION, 2017-2025($MILLION)

TABLE 07. EYE-DROP AND LUBRICANTS MARKET FOR EYE DISEASES, BY TYPE, 2017–2025 ($MILLION)

TABLE 08. EYE-DROP AND LUBRICANTS MARKET FOR EYE DISEASES, BY REGION, 2017–2025 ($MILLION)

TABLE 09. EYE-DROP AND LUBRICANTS MARKET FOR EYE CARE, BY REGION, 2017–2025 ($MILLION)

TABLE 10. EYE-DROP AND LUBRICANTS MARKET FOR OTHER APPLICATION, BY REGION, 2017–2025 ($MILLION)

TABLE 11. EYE DROPS AND LUBRICANT MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)

TABLE 12. NORTH AMERICA EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 13. NORTH AMERICA EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 14. NORTH AMERICA EYE DROPS AND LUBRICANT MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 15. U.S. EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 16. U.S. EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 17. CANADA EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 18. CANADA EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 19. MEXICO EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 20. MEXICO EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 21. EUROPE EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 22. EUROPE EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 23. EUROPE EYE DROPS AND LUBRICANT MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 24. GERMANY EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 25. GERMANY EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 26. FRANCE EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 27. FRANCE EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 28. UK EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 29. UK EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 30. ITALY EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 31. ITALY EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 32. SPAIN EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 33. SPAIN EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 34. REST OF EUROPE EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 35. REST OF EUROPE EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 36. ASIA-PACIFIC EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 37. ASIA-PACIFIC EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 38. ASIA-PACIFIC EYE DROPS AND LUBRICANT MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 39. JAPAN EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 40. JAPAN EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 41. CHINA EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 42. CHINA EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 43. INDIA EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 44. INDIA EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 45. AUSTRALIA EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 46. AUSTRALIA EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 47. SOUTH KOREA EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 48. SOUTH KOREA EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 49. REST OF ASIA-PACIFIC EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 50. REST OF ASIA-PACIFIC EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 51. LAMEA EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 52. LAMEA EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 53. LAMEA EYE DROPS AND LUBRICANT MARKET, BY COUNTRY, 2017–2025 ($MILLION)

TABLE 54. BRAZIL EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 55. BRAZIL EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 56. SAUDI ARABIA EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 57. SAUDI ARABIA EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 58. REST OF LAMEA EYE DROPS AND LUBRICANT MARKET, BY TYPE, 2017–2025 ($MILLION)

TABLE 59. REST OF LAMEA EYE DROPS AND LUBRICANT MARKET, BY APPLICATION, 2017–2025 ($MILLION)

TABLE 60. AKORN CONSUMER HEALTH: COMPANY SNAPSHOT

TABLE 61. AKORN CONSUMER HEALTH: PRODUCT PORTFOLIO

TABLE 62. ALLERGAN: COMPANY SNAPSHOT

TABLE 63. ALLERGAN: OPERATING SEGMENTS

TABLE 64. ALLERGAN: PRODUCT PORTFOLIO

TABLE 65. J&J: COMPANY SNAPSHOT

TABLE 66. J&J: OPERATING SEGMENTS

TABLE 67. J&J: PRODUCT PORTFOLIO

TABLE 68. NOVARTIS AG: COMPANY SNAPSHOT

TABLE 69. NOVARTIS: OPERATING SEGMENTS

TABLE 70. NOVARTIS AG: PRODUCT PORTFOLIO

TABLE 71. PFIZER: COMPANY SNAPSHOT

TABLE 72. PFIZER: OPERATING SEGMENTS

TABLE 73. PFIZER: PRODUCT PORTFOLIO

TABLE 74. PRESTIGE BRANDS: COMPANY SNAPSHOT

TABLE 75. PRESTIGE BRANDS: PRODUCT PORTFOLIO

TABLE 76. SAGER PHARMA: COMPANY SNAPSHOT

TABLE 77. SAGER PHARMA: PRODUCT PORTFOLIO

TABLE 78. ROHTO: COMPANY SNAPSHOT

TABLE 79. ROHTO: PRODUCT PORTFOLIO

TABLE 80. SIMILASAN: COMPANY SNAPSHOT

TABLE 81. SIMILASAN: PRODUCT PORTFOLIO

TABLE 82. VALEANT: COMPANY SNAPSHOT

TABLE 83. VALEANT: OPERATING SEGMENTS

TABLE 84. VALEANT: PRODUCT PORTFOLIO LIST OF FIGURES

FIGURE 01. SEGMENTATION OF EYE DROPS AND LUBRICANTS MARKET

FIGURE 02. TOP INVESTMENT POCKETS, 2017

FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2015-2018*

FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015-2018* (%)

FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2015-2018*

FIGURE 06. MODERATE BARGAINING POWER OF SUPPLIERS

FIGURE 07. HIGH BARGAINING POWER OF BUYERS

FIGURE 08. HIGH THREAT OF SUBSTITUTION

FIGURE 09. HIGH THREAT OF NEW ENTRANT

FIGURE 10. MODERATE COMPETITIVE RIVALRY

FIGURE 11. TOP PLAYER POSITIONING, 2017

FIGURE 12. GLOBAL EYE DROPS AND LUBRICANTS MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES

FIGURE 13. COMPARATIVE ANALYSIS OF EYE DROPS AND LUBRICANTS MARKET FOR ANTIBIOTICS, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 14. COMPARATIVE ANALYSIS OF EYE DROPS AND LUBRICANTS MARKET FOR HORMONES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 15. COMPARATIVE ANALYSIS OF EYE DROPS AND LUBRICANTS MARKET FOR ARTIFICIAL TEARS, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 16. COMPARATIVE ANALYSIS OF EYE DROPS AND LUBRICANTS MARKET FOR OTHER TYPES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 17. EYE-DROP AND LUBRICANTS MARKET FOR DRY EYE, 2017–2025 ($MILLION)

FIGURE 18. EYE-DROP AND LUBRICANTS MARKET FOR GLAUCOMA, 2017–2025 ($MILLION)

FIGURE 19. EYE-DROP AND LUBRICANTS MARKET FOR CONJUNCTIVITIS, 2017–2025 ($MILLION)

FIGURE 20. EYE-DROP AND LUBRICANTS MARKET FOR REFRACTIVE ERRORS, 2017–2025 ($MILLION)

FIGURE 21. EYE-DROP AND LUBRICANTS MARKET FOR OTHER EYE DISEASES, 2017–2025 ($MILLION)

FIGURE 22. COMPARATIVE ANALYSIS OF EYE-DROP AND LUBRICANTS MARKET FOR EYE DISEASES, BY COUNTRY, 2017 & 2025 ($MILLION)

FIGURE 23. COMPARATIVE SHARE ANALYSIS OF EYE-DROP AND LUBRICANTS MARKET FOR EYE CARE, BY COUNTRY, 2017 & 2025 (%)

FIGURE 24. COMPARATIVE SHARE ANALYSIS OF EYE-DROP AND LUBRICANTS MARKET FOR EYE-DROP AND LUBRICANTS MARKET FOR OTHER APPLICATION, BY COUNTRY, 2017 & 2025 (%)

FIGURE 25. ALLERGAN: NET SALES, 2016–2018 ($MILLION)

FIGURE 26. ALLERGAN: REVENUE SHARE BY SEGMENT, 2018 (%)

FIGURE 27. J&J: NET SALES, 2015–2017 ($MILLION)

FIGURE 28. J&J: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 29. J&J: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 30. NOVARTIS: NET SALES, 2015–2017 ($MILLION)

FIGURE 31. NOVARTIS: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 32. NOVARTIS: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 33. PFIZER: NET SALES, 2015–2017 ($MILLION)

FIGURE 34. PFIZER: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 35. PFIZER: REVENUE SHARE BY REGION, 2017 (%)

FIGURE 36. ROHTO: NET SALES, 2016–2018 ($MILLION)

FIGURE 37. ROHTO: REVENUE SHARE BY PRODUCT SEGMENT, 2018 (%)

FIGURE 38. ROHTO: REVENUE SHARE BY REGION, 2018 (%)

FIGURE 39. VALEANT: NET SALES, 2015–2017 ($MILLION)

FIGURE 40. VALEANT: REVENUE SHARE BY SEGMENT, 2017 (%)

FIGURE 41. VALEANT: REVENUE SHARE BY REGION, 2017 (%